Fetal hemoglobin quantification per red blood cell allows to determine protective thresholds in sickle cell disease

American Journal of Hematology
Nicolas HebertPablo Bartolucci

Abstract

Polymerization of the sickle hemoglobin (HbS) is a key determinant of sickle cell disease (SCD), an inherited blood disorder. Fetal hemoglobin (HbF) is a major modulator of the disease severity by both decreasing HbS intracellular concentration and inhibiting its polymerization. However, heterocellular distribution of HbF is common in SCD. For HbS polymerization inhibition, the hypothesis of an "HbF per red blood cell (HbF/RBC) threshold" requires accurate measurement of HbF in individual RBC. To date, HbF detection methods are limited to a qualitative measurement of RBC populations containing HbF - the F cells, which are variable. We developed an accurate method for HbF quantification in individual RBC. A linear association between mean HbF content and mean RBC fluorescence by flow cytometry, using an anti-Human-HbF antibody, was obtained from non-SCD subjects presenting homogeneous HbF distribution. This correlation was then used to measure HbF/RBC. Hydroxyurea (HU) improves SCD clinical manifestations, mainly through its ability to induce HbF synthesis. HbF distribution was analyzed in 14 SCD patients before and during HU treatment. A significant decrease in RBC population containing less than 2 pg of HbF/RBC was observed. T...Continue Reading

References

Apr 12, 1990·The New England Journal of Medicine·G P RodgersA W Nienhuis
Aug 9, 1990·The New England Journal of Medicine·M A GoldbergH F Bunn
Mar 1, 1980·The Journal of Clinical Investigation·D R PowarsS P Azen
Aug 1, 1984·The Journal of Clinical Investigation·O S PlattD G Nathan
Jun 9, 1994·The New England Journal of Medicine·O S PlattP P Klug
Jun 24, 1998·The Journal of Clinical Investigation·R S FrancoD L Rucknagel
Dec 18, 2001·Cytometry·K K PannuS B Iyer
Jan 30, 2003·American Journal of Hematology·Martin H SteinbergFranca Barton
Apr 4, 2003·JAMA : the Journal of the American Medical Association·Martin H SteinbergMichael Terrin
Dec 12, 1959·Nature·K BETKEI SCHLICHT
Feb 15, 2007·The Pharmacogenomics Journal·Q MaM H Steinberg
Mar 28, 2008·The New England Journal of Medicine·Orah S Platt
Oct 10, 2009·Therapeutics and Clinical Risk Management·Nm Wiles, J Howard
Jul 7, 2010·Lab on a Chip·Paul AbbyadAntigoni Alexandrou
Nov 14, 2013·Blood·Martin H SteinbergAbdulrahman Alsultan
Jan 31, 2014·American Journal of Hematology·Hany ElmariahMarilyn J Telen
Mar 4, 2014·American Journal of Hematology·Eduard J van BeersGregory J Kato
Nov 21, 2015·Journal of the American Society of Nephrology : JASN·Pablo BartolucciVincent Audard
Jul 22, 2016·Blood·Kate GardnerSwee Lay Thein
Sep 7, 2016·The Journal of Clinical Investigation·Christian BrendelDavid A Williams
Dec 10, 2016·PloS One·Marta de Almeida SantiagoAna Cristina Martins de Almeida Nogueira
Mar 2, 2017·The New England Journal of Medicine·Jean-Antoine RibeilMarina Cavazzana
Apr 8, 2017·Blood·William A Eaton, H Franklin Bunn
Apr 19, 2018·The New England Journal of Medicine·Alexis A ThompsonMarina Cavazzana
Feb 20, 2020·American Journal of Hematology·Seda S ToluCaterina P Minniti

❮ Previous
Next ❯

Citations

Feb 26, 2021·Current Opinion in Hematology·Eugene Khandros, Gerd A Blobel
Oct 11, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tolulope O Rosanwo, Daniel E Bauer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.